Tabla de Contenidos:
  • Why a children's vaccine initiative
  • Progress toward universal childhood immunization
  • Limits of the expanded program on immunization
  • Children's vaccine initiative
  • Characteristics of CVI vaccines
  • Concerns about the CVI
  • Relevance of the CVI to the U.S. immunization efforts
  • Status of immunization efforts in the United States
  • Role for the CVI in the United States
  • Resources and infrastructure
  • Resources in the United States
  • U.S. federal agencies and programs
  • U.S. state vaccine manufacturers
  • U.S.-based pharmaceutical firms
  • Development-stage companies
  • Nongovernmental organizations
  • International resources
  • Multilateral organizations
  • Public-sector resources
  • Private-sector resources
  • Nongovernmental organizations
  • Vaccine demand and supply
  • Global demand and supply
  • Demand and supply in the United States
  • Investing in new and improved vaccines
  • Market considerations
  • Liability
  • Stages of vaccine development
  • Priority setting
  • Basic and applied research
  • Clinical evaluation
  • Licensure
  • Production
  • Recommendations for use.
  • (cont) Procurement
  • Distribution and delivery
  • Surveillance
  • Strategy to enhance U.S. participation in the children's vaccine initiative
  • National vaccine authority
  • Relevant Intellectual Property Rights Law
  • National Vaccine Injury Compensation Program
  • Regulatory aspects of vaccine development, manufacture and distribution
  • Strategies for achieving full U.S. participation in the children's vaccine initiative
  • Public Health Service Act (1944)
  • National vaccine program legislation
  • Immunization schedules
  • Historical record of vaccine product license holders in the United States
  • Working group participants
  • Committee and staff biographies
  • Acronyms.